Aim: The precise mechanism by which prophylactic splenectomy reduces hepatic ischemia-reperfusion injury (IRI) are still unclear. In this study, we focused on the histological changes of spleen during hepatic IRI, and tested how splenectomy provided cytoprotective effects against hepatic IRI.
INTRODUCTION
It is well known that the spleen removes aging erythrocytes and regulates iron balance and immune response. 1 During a fatal infectious status or endotoxemia, spleen provides an appropriate environment for the priming and activation of cytotoxic and natural killer T cells by antigen-presenting cells. 2, 3 In addition to these well-known functions, recent studies suggest that the spleen possesses further functions such as regulation of portal venous pressure, production of growth factors, and non-specific immune response. 4 In the settings of liver transplantation, especially when surgeons use a small-for-size graft, splenectomy has been regarded as one of the optimal treatments against a portal hypertension, and its indication has been extended in recent years. In addition, splenectomy has been used as one of the indispensable options in ABO incompatible transplantations. 5, 6 Our institution has published novel data showing that splenectomy led to dual cytoprotective effects: preventing excessive portal vein hepatic inflow and eliminating splenic inflammatory cell recruitment into the liver in the setting of rat small-for-size graft liver transplantation models.
METHODS

Animals and experimental design
M ALE WISTAR RATS, 250-300 g in weight, were supplied by Japan SLC (Hamamatsu, Japan). The animals were housed under standard conditions, and fed rodent chow and water. All surgical procedures and care were carried out in accordance with the guidelines for animal experiments of the National Institutes of Health (NIH publication 86-23, revised 1985) and approved by the review board of Mie University (Tsu, Japan). Animals were assigned randomly to four experimental groups as follows 1 : SHAM, only laparotomy 2 ; IRI 3 ; and splenectomy (SPN) + IRI. 4 After an overnight fast, rats were anesthetized with isoflurane and a midline laparotomy was carried out after the skin was shaved. In the SPN group, the spleen was removed. In the IRI group, the liver was isolated and complete ischemia of the median and left hepatic lobes was induced by clamping the left branches of the portal vein and the hepatic artery for 90 min. The right hepatic lobe and the caudate lobe were perfused to prevent intestinal congestion. The duration of 90 min for hepatic ischemia was used based on the previous several studies researching hepatic IRI. 7, 9, 10 This type of hepatic ischemia induces extremely severe parenchymal damage represented by high levels of transaminases, but allowed us to observe the obvious histological changes of spleen during hepatic IRI. For the SPN + IRI group, the spleen was removed, followed by immediate hepatic IRI. For the SHAM group, the sham operation involved the same technique and exposure, but without splenectomy or IRI. At each of the indicated time points (6 and 24 h after the clamp being removed), blood samples, livers, and spleens were collected for further analysis. In addition, to compare the spleen of the IRI group with spleens before hepatic IRI, a further five rats were killed and naive spleens were collected.
Assessment of liver injury
Serum aspartate aminotransferase (sAST) and alanine aminotransferase (sALT) levels were measured with Test Wako for transaminase (Wako Pure Chemical Industries Ltd, Osaka, Japan) according to the manufacturer's instructions. Liver specimens were fixed with a 10% buffered formalin solution, embedded in paraffin, and processed for hematoxylin-eosin (HE) staining. For morphologic analysis of liver damage, the histopathologic scoring method was carried out according to a modification of Suzuki's histological classification with HE staining. 11 In this classification, sinusoidal congestion, cell vacuolization, and hepatocyte necrosis were graded from 0 to 4 as follows. Liver necrosis: 0, none; 1, single cell necrosis; 2, <30%; 3, 31-60%; 4, >60%. The same classification was used for vacuolization and sinusoidal congestion: 0, none; 1, minimal; 2, mild; 3, moderate; 4, severe.
Myeloperoxidase assay
Myeloperoxidase (MPO) activity was evaluated as previously described. 12 Frozen tissue was homogenized in an iced solution of 0.5% hexadecyltrimethylammonium (Sigma, St. Louis, MO, USA) and 50 mmol/L potassium phosphate buffer solution (Sigma) with pH adjusted to 5.6. Samples were centrifuged at 17 900 g for 15 min at 4°C. Supernatants (100 μL) were mixed in a solution of hydrogen peroxide-sodium acetate and tetramethylbenzidine (Sigma). The absorbance change was measured spectrophotometrically at 655 nm. The quantity of enzyme degrading 1 mol/L peroxide per min at 25°C/g tissue was defined as 1 U of MPO activity.
Assessment of leukocyte migration
Sections were deparaffinized and rehydrated with phosphate-buffered saline, followed by microwave pretreatment for antigen retrieval. The frozen sections, embedded in Tissue Tec OCT compound (Sakura Finetec, Tokyo, Japan) and snap-frozen in liquid nitrogen, were fixed in acetone at room temperature for 10 min after air drying for 1 h. Immunohistochemical staining using ED1 and R73 antibodies was carried out with the paraffinembedded sections and frozen sections, respectively.
Next, both sections were incubated in 0.3% H 2 O 2 in methanol to block endogenous peroxidase activity.
Non-specific binding sites were blocked by a 20-min incubation in normal blocking serum. Primary antibodies against ED-1 (macrophage; Chemicon International, Temecula, CA, USA) and Rat αβ TCR, clone R73 (a/ß T cells; Biolegend, San Diego, CA, USA) were added at optimal dilutions. Secondary antibody and ABC reagent were applied according to the manufacturer's instructions (Vectastain ABC kit; Vector Laboratories, Burlingame, CA, USA). Color development was induced by incubation with 3,3-diaminobenzidine substrate for 5-8 min, and specific staining was visualized by light microscopy. The neutrophils were stained using a naphthol AS-D chloroacetate esterase staining kit (Sigma). Neutrophils were identified by their nuclear morphology and bright red positive staining. The results were evaluated by counting labeled cells in triplicate in 20 high-power (×200) fields per section. 13 Assessment of histological changes in splenic parenchyma thickness was significantly more frequent in autopsied patients with severe congestive heart failure, cirrhosis, and hepatic portal sclerosis, which suggested that most cases of splenic capsular thickening are caused by splenic congestion with organization of capsular and subcapsular hemorrhages.
14 These findings allowed us to hypothesize that the spleen might show crucial histological changes during hepatic IRI, which might also provide us important clues to reveal how splenectomy ameliorates hepatic IRI. First, we observed the findings of HE staining using spleen harvested at the status of pre-clamp, during the clamp, 5 min after removing the clamp, 6 h after IRI, and 24 h after IRI. We then evaluated the degree of congestion of splenic red pulp and splenic capsule thickening.
RNA extraction and reverse transcriptionpolymerase chain reaction
Total RNA was extracted from the frozen tissue samples from spleens using a TRIzol (Life Technologies, Carlsbad, CA, USA) and the RNA concentration was then determined using a spectrophotometer. Five micrograms of RNA was reverse transcribed using Platinum TaqDNA polymerase SuperMix (Invitrogen, Carlsbad, CA, USA) on a Gene Amp PCR system (Applied Biosystems, Foster City, CA, USA). The resulting cDNA (1 μg) was used as a template for subsequent polymerase chain reaction (PCR) using the following primers: interleukin (IL)-2 sense (5′-TTCATCAGCAATATC AGAGT) and antisense (5′-AAGTAGTCGTTATAGTCTCA); and glyceraldehyde-3-phosphate dehydrogenase sense (5′-GCTGAAGGTCGGTGTGAAC) and antisense (5′-GCT CCTGGAAGATGGTGATG). The PCR products were analyzed in ethidium bromide-stained 2% agarose gel and scanned using a UVP DigDoc-it Digital Imaging System (UVP, Uppland, CA,USA).
Measurement of plasma levels of IL-2 of the splenic vein
Plasma IL-2 (Quantikine; R&D System, Minneapolis, MN, USA) and tumor necrosis factor-α (TNF-α) (Ready-SET-Go; eBioscience) levels from the splenic vein were determined using commercially available enzyme-linked immunosorbent assays (ELISAs: eBioscience, San Diego, CA, USA) according to the manufacturer's instructions.
Measurement of portal venous pressure and flow
The animals were fasted overnight prior to measurement. After anesthesia, a midline incision was made. The main portal vein (approximately 1 cm in length) was dissociated and exposed by blunt dissection. An incision was made followed by placement of an electromagnetic probe with an appropriate caliber connected with the electromagnetic flowmeter into the portal vein to measure the portal venous flow (PVF). To measure portal venous pressure (PVP), a segment of the mesenteric branch vein was cannulated with a 24-g cannula needle, and the tip of the cannula was advanced just into the trunk of the superior mesenteric vein. Pressure measurement lasted for 3 min, and the average value was regarded as the PVP. The PVP was recorded by a pressure transducer using a multichannel recorder (Nikon Kohden, Tokyo, Japan).
Splenic vein clamp model
To determine whether splenic congestion by itself induces liver damage even in the absence of hepatic IRI, we additionally established a temporal splenic vein clamp (SVC) model. After anesthesia, the root of the splenic vein was dissociated and exposed by blunt dissection; clamping of the splenic vein for 90 min induced splenic congestion. At 6 and 24 h after the clamp, animals were killed and blood samples and spleen were collected by the method described above. We evaluated the sALT, MPO activity, and hepatic macrophage infiltration of the SVC, compared with the SHAM group.
Statistical analysis
Data are expressed as the mean ± standard deviation. Twogroup comparisons were analyzed by the two-tailed Student t-test and otherwise by two-tailed Cochran-Cox test. Statistical analyses with respect to the PVP and PVF were carried out using two-way repeated measures ANOVA with Bonferroni's multiple comparison tests. Probability values of <0.05 were considered statistically significant.
RESULTS
Splenectomy improves hepatic function and ameliorates hepatocellular injury after IRI W E FIRST EXAMINED the levels of sAST and sALT as markers of hepatic injury, and histology of the liver in the four treatment groups (SHAM, SPN, IRI, and SPN + IRI) at 6 and 24 h after reperfusion. There was no significant difference between the SHAM and SPN groups at any time points after hepatic IRI. The liver of the SPN + IRI group showed less damage, as evidenced by significantly reduced sAST levels (U/L) at 6 h (sAST, 19 323 ± 7074 vs. 52 348 ± 13 610, P = 0.0016; sALT, 8925 ± 2694 vs. 20 565 ± 4218, P = 0.0006; n = 6/group), after IRI, compared with controls (Fig. 1a,b) . In the IRI group, AST/ALT showed extremely high levels, probably due to the 90-min ischemia, that were comparable to previous reports. 9, 10, 15 Lower aminotransferase levels were associated with improved histological preservation in SPN + IRI group. The liver of the SPN + IRI group Figure 1 Liver function during hepatic ischemia-reperfusion injury (IRI) in rats. Serum aspartate aminotransferase (AST) (a) and alanine aminotransferase (ALT) (b) levels were significantly lower at 6 h after reperfusion in the splenectomy (SPN) + IRI group compared with the IRI alone group (IRI, n = 6; SPN + IRI, n = 6). Hematoxylin-eosin staining and macroscopic findings (c) of IRI alone (c1-c3) and SPN + IRI (c4-c6) livers show evidence that splenectomy resulted in a significant improvement of liver preservation at 6 h (c1, c4) and 24 h (c2, c5). (d) Suzuki's score showed that the SPN + IRI group had significantly preserved lobular architecture and reduced intrasinusoidal congestion compared with the IRI alone group at 6 h (IRI, n = 11; SPN + IRI, n = 9) and 24 h after reperfusion (IRI, n = 10; SPN + IRI, n = 8).
had significantly preserved lobular architecture and reduced sinusoidal/vascular congestion compared with the IRI alone group (Fig. 1c ). Suzuki's score was significantly lower in the SPN + IRI group at 6 h (5.0 ± 2.0 vs. 10.9 ± 1.8, P < 0.0001; n = 9-11/group) and 24 h after reperfusion (8.2 ± 2.1 vs. 10.7 ± 1.8, P < 0.0001, n = 8-10/group), compared with the IRI alone group (Fig. 1d) .
Splenectomy reduces leukocyte migration into damaged liver after IRI
To evaluate leukocyte migration of the damaged liver after hepatic IRI, we found that liver tissues of the SPN + IRI group had significantly reduced MPO activity compared with the IRI alone group at 6 h (4.3 ± 1.2 Unit/g vs. 26.8 ± 10.7 Unit/g, P < 0.0001; n = 5/group) after reperfusion (Fig. 2a) . Next, we counted macrophages (ED-1), neutrophils (naphthol AS-D chloroacetate esterase technique), and lymphocytes (R-73) by immunohistochemical staining. The SPN + IRI group showed significantly decreased intrahepatic infiltration of ED-1-positive cells (2.2 ± 1.6/ high-power field [HPF] vs. 8.0 ± 2.4/HPF, P = 0.016; n = 5/ group) and neutrophil infiltration (21.0 ± 8.4/HPF vs. 39.2 ± 14.6/HPF, P = 0.039; n = 4/group) into the damaged liver, compared to the IRI alone group at 6 h (Fig. 2b) . In contrast, in terms of the intrahepatic infiltration of lymphocytes and the number of R73-positive cells, there was no significant difference between the SPN + IRI and IRI alone groups at 6 h (SPN + IRI vs. IRI, 5.3 ± 2.1/HPF vs. 6.2 ± 3.1/HPF, P = 0.628; n = 5/group).
Splenectomy does not affect PVP or PVF during IRI
To determine the impact of splenectomy on portal hemodynamics, which also affects the outcome of hepatic IRI, we measured the PVP and PVF during IRI with or without splenectomy. The portal clamp significantly decreased PVF (Fig. 3a) and increased PVP (Fig. 3b) . Nevertheless, there was no difference in the PVP and PVF between two groups at any time points after IRI, which indicates that there might be other reasons why splenectomy attenuates hepatic IRI.
Hepatic IRI induces severe splenic congestion of red pulp and capsule thickening
To investigate the impact of hepatic IRI on the spleen, we examined the histology of spleen of the IRI group at the indicated time points (before clamp, during the clamp, 5 min after clamp off, and 6 and 24 h after reperfusion). As shown in Figure 3 (c), splenic red pulp during the vascular clamps showed a noted congestion (Fig. 3c, panel 2 ) compared with the naive spleens before hepatic IRI (Fig. 3c,  panel 1 ). By 5 min after removal of the clamp, however, the congestion was significantly reduced (Fig. 3c, panel 3) . Interestingly, we found that the spleen capsule was significantly thickened and the sinus of the spleen was enlarged due to recongestion at 6 h after reperfusion (Fig. 3c, panel 4 ). This damage of the spleen was notably enhanced by 24 h after reperfusion (Fig. 3c, panel 5 ).
Hepatic IRI upregulates splenic IL-2 expression that increases splenic venous plasma level of IL-2
We next investigated the splenic expression of IL-2, a cytokine that has been regarded as a cofactor for induction of activated macrophages. 16 As shown in Figure 3(d) , spleens of the IRI group showed markedly increased expression of IL-2 compared with naive spleens at 6 h (0.38 ± 0.01 vs. 0.08 ± 0.02, P = 0.002; n = 5/group) and 24 h after reperfusion (0.51 ± 0.05 vs.0.08 ± 0.02, P = 0.032; n = 5/group). However, mRNA expressions of IL-1b, TNF-α, and IL-6 showed no significant difference between the spleens of the SHAM and IRI groups (data not shown). Furthermore, we also measured the levels of IL-2 and TNF-α, which are well-known major macrophage inducers, in splenic vein by ELISA with or without splenectomy. The IRI group had markedly increased splenic venous plasma levels of IL-2 compared with the SPN + IRI group at 6 h (101.3 ± 17.2 pg/mL vs. 20.5 ± 21.5 pg/mL, P = 0.0023) (Fig. 3e) . However, in terms of splenic venous TNF-α levels, there were no significant differences between the IRI and SPN + IRI groups at 6 h (9.3 ± 2.4 pg/mL vs. 9.4 ± 2.1 pg/mL, P = 0.988).
Temporal SVC induces liver damage caused by macrophage/monocyte infiltration despite absence of hepatic IRI To investigate whether splenic congestion itself induces liver damage, we established an SVC model without hepatic IRI. The level of sALT was significantly increased in the SVC group compared with the SHAM group at 6 h (161 ± 28 IU/L vs. 82 ± 15 IU/L, P = 0.008; n = 4/group) after the clamp was removed (Fig. 4a) . Hematoxylin-eosin staining of the liver tissue of the SVC group showed intrasinusoidal/vascular congestion and vacuolization, compared with the SHAM group at 6 h after declamping (Fig. 4b) . According to Suzuki's score, these changes of the liver had disappeared within 24 h after the clamp being removed (6 h, 3.75 ± 0.43 vs. 0.50 ± 0.58, P = 0.001; 24 h, 1.00 ± 0.81 vs. 0.75 ± 0.43, P = 0.62; n = 4/group). The cell counts of ED-1-positive cells in the liver (7.2 ± 2.1/HPF vs. 2.5 ± 1.4/HPF, P = 0.003; n = 4/group) and levels of MPO activity (1.2 ± 0.3 Unit/g vs. 2.5 ± 1.1 Unit/g, P = 0.04; n = 4/group) were significantly enhanced in the SVC group, as compared with SHAM groups at 6 h E136
( Fig. 4c,d ). As shown by Figure 4 (e), splenic red pulp during SVC showed strong congestion (Fig. 4e, panel 1) . By 5 min after clamp removal, it immediately disappeared (Fig. 4e, panel 2) ; then splenic congestion reoccurred at 6 h after clamp removal. Nevertheless, this series of histological changes is much milder than those of hepatic IRI models. Furthermore, the spleen of the SVC group showed markedly increased expression of IL-2 compared with the naive spleens at 6 h (0.39 ± 0.08. vs. 0.21 ± 0.10, P = 0.047; n = 4/group), but not at 24 h (Fig. 4f) . Taken together, these data suggest that splenic congestion caused by the portal vein clamp induced liver injury and macrophage infiltration to the liver through the splenic IL-2 upregulation, but it did not last 24 h without hepatic IRI. Role
DISCUSSION
I
N THIS STUDY, we found that during hepatic IRI the spleen showed severe sinusoidal congestion, then developed further parenchymal damage and capsular thickness at 6 and 24 h post-IRI. These changes are usually observed in the spleen of prehepatic portal hypertensive rats 17 or specific diseases related to splenic congestion. 14 In addition, portal hypertension found in small-for-size grafts is thought to be one of the main causes of post-transplant graft dysfunction. 18 Splenectomy for small-for-size grafts is usually used to reduce PVP and excessive shear stress on the liver. 4, 19, 20 We consider that splenic congestion due to excessive PVP caused by a hepatic hilar clamp also influences this damage. Indeed, the PVP increased significantly during ischemia compared with that of the pre-clamped status, and gradually decreased after reperfusion. When we compared the PVP of animals with or without splenectomy, there was no statistically significant difference at any time point, suggesting that there might be an alternative explanation, other than modulation of PVP, for the attenuation of hepatic IRI by splenectomy.
Our current data showed that the levels of IL-2, a type of cytokine that regulates the activities of monocytes/ macrophages, were significantly increased in the splenic vein and splenic tissue in the IRI group. In contrast, prophylactic splenectomy profoundly sheltered liver damage and leukocyte infiltration after hepatic ischemia reperfusion, which might be provided by an abolishment of the splenic IL-2 excretion. Based on these data, we established SVC models without hepatic IRI, which allowed us to investigate whether splenic congestion itself affects liver function. Interestingly, we found that SVC by itself produced a certain level of liver injury and macrophage infiltration, even though there was no hepatic IRI. However, this liver injury was not as severe as that of IRI models, and morphologic liver damage of the SVC group did not last 24 h. In this specific setting, splenic IL-2 expression was enhanced at 6 h after removal of the clamp, but this upregulation had also settled down at 24 h. These data suggest that splenic congestion due to excessive PVP just triggers splenic damage to produce IL-2 and employment of macrophages to the liver at an early phase of IRI. It was therefore considered that circulatory inflammatory cytokines during hepatic IRI in the presence of spleen causes additional splenic injury, particularly at 6 and 24 h after reperfusion, which also accelerates the IL-2 production from the spleen, resulting in acceleration of hepatic injury. Previous studies on the role of splenectomy in hepatic IRI models showed that splenectomy ameliorated the injury to other organs such as lungs, small intestines, and kidneys after hepatic IRI. 8, 21 Currently, there is increasing evidence that hepatic IRI causes damage to other organs, such as lung, 22 heart, 23 and even multiple organ dysfunction. 24 Therefore, we consider that the spleen could be one of the organs injured by hepatic IRI, and the damaged spleen plays a key role in exacerbation of IRI.
In the clinical setting of organ transplantations, IL-2 is regarded as an important cytokine in terms of the control of immunosuppressive treatments and IRI. For example, soluble production of IL-2 reflects individual response to immunosuppressive drugs and graft outcome and is regarded as a predictive biomarker of acute rejection. 25 Interleukin-2 receptor antagonists are frequently used as induction therapy in liver transplant recipients to decrease the risk of acute rejection. 26 In contrast, local increase in IL-2 in a lung allograft occurred in the development of early allograft dysfunction due to IRI after dog lung transplantation. 27 Hepatic IRI insults cause up to 10% of early graft dysfunction and can also leads to significantly higher incidence of acute and chronic rejection, 28, 29 suggesting that IRI interacts adversely with acute rejections. Our current data showed that splenectomy significantly reduced IL-2 level in the portal system, and cancels the vicious cycles caused by the complex of splenic congestion and hepatic IRI.
In conclusion, the spleen accelerates hepatic IRI, because splenic congestion and its parenchymal damage during hepatic ischemia-reperfusion promote splenic IL-2 excretion and macrophage infiltration within the liver, which in turn exacerbates hepatic injury. In clinical settings, splenectomy, if necessary, is recommended prior to liver graft implantation or liver resection under intermittent hepatic inflow occlusion.
